Clinical Trial: A Clinical Trial of SIBP-A16 Injection in Healthy Adults

U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07106918) titled 'A Clinical Trial of SIBP-A16 Injection in Healthy Adults' on July 30.

Brief Summary: This study is a randomized, double-blind, placebo/positive control Phase Ia clinical trial evaluating the safety, tolerability, and pharmacokinetics of SIBP-A16 injection in healthy adults

Study Start Date: Aug. 18

Study Type: INTERVENTIONAL

Condition: Respiratory Syncytial Virus (RSV)

Intervention: BIOLOGICAL: SIBP-A16 injection

Single administration via intramuscular or intravenous injection. All participants received a single injection of the corresponding dose.

BIOLOGICAL: Nirsevimab

Single administration via intramuscular.

OTHER: SIBP-...